Cargando…
Drug pipeline 2Q22 — a downturn in approvals
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group US
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361956/ https://www.ncbi.nlm.nih.gov/pubmed/35945433 http://dx.doi.org/10.1038/s41587-022-01413-z |
| _version_ | 1784764632377851904 |
|---|---|
| author | DeFrancesco, Laura |
| author_facet | DeFrancesco, Laura |
| author_sort | DeFrancesco, Laura |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9361956 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Nature Publishing Group US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93619562022-08-10 Drug pipeline 2Q22 — a downturn in approvals DeFrancesco, Laura Nat Biotechnol Data Page Nature Publishing Group US 2022-08-09 2022 /pmc/articles/PMC9361956/ /pubmed/35945433 http://dx.doi.org/10.1038/s41587-022-01413-z Text en © Springer Nature America, Inc. 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Data Page DeFrancesco, Laura Drug pipeline 2Q22 — a downturn in approvals |
| title | Drug pipeline 2Q22 — a downturn in approvals |
| title_full | Drug pipeline 2Q22 — a downturn in approvals |
| title_fullStr | Drug pipeline 2Q22 — a downturn in approvals |
| title_full_unstemmed | Drug pipeline 2Q22 — a downturn in approvals |
| title_short | Drug pipeline 2Q22 — a downturn in approvals |
| title_sort | drug pipeline 2q22 — a downturn in approvals |
| topic | Data Page |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361956/ https://www.ncbi.nlm.nih.gov/pubmed/35945433 http://dx.doi.org/10.1038/s41587-022-01413-z |
| work_keys_str_mv | AT defrancescolaura drugpipeline2q22adownturninapprovals |